Obesity and cancer: mechanistic insights from transdisciplinary studies
- PMID: 26373570
- PMCID: PMC4631382
- DOI: 10.1530/ERC-15-0400
Obesity and cancer: mechanistic insights from transdisciplinary studies
Abstract
Obesity is associated with a range of health outcomes that are of clinical and public health significance, including cancer. Herein, we summarize epidemiologic and preclinical evidence for an association between obesity and increased risk of breast and prostate cancer incidence and mortality. Moreover, we describe data from observational studies of weight change in humans and from calorie-restriction studies in mouse models that support a potential role for weight loss in counteracting tumor-promoting properties of obesity in breast and prostate cancers. Given that weight loss is challenging to achieve and maintain, we also consider evidence linking treatments for obesity-associated co-morbidities, including metformin, statins and non-steroidal anti-inflammatory drugs, with reduced breast and prostate cancer incidence and mortality. Finally, we highlight several challenges that should be considered when conducting epidemiologic and preclinical research in the area of obesity and cancer, including the measurement of obesity in population-based studies, the timing of obesity and weight change in relation to tumor latency and cancer diagnosis, and the heterogeneous nature of obesity and its associated co-morbidities. Given that obesity is a complex trait, comprised of behavioral, epidemiologic and molecular/metabolic factors, we argue that a transdisciplinary approach is the key to understanding the mechanisms linking obesity and cancer. As such, this review highlights the critical need to integrate evidence from both epidemiologic and preclinical studies to gain insight into both biologic and non-biologic mechanisms contributing to the obesity-cancer link.
Keywords: NSAIDs; aspirin; breast cancer; cholesterol; epidemiology; insulin; mechanisms; metformin; mouse models; obesity; prostate cancer; screening; statins; transdisciplinary; weight loss.
© 2015 Society for Endocrinology.
Conflict of interest statement
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d06/4631382/43967d4fbb96/nihms731694f1.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d06/4631382/ebb488f5ba2f/nihms731694f2.gif)
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d06/4631382/7083e8b7ae80/nihms731694f3.gif)
![Figure 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d06/4631382/b54ff744fd8b/nihms731694f4.gif)
![Figure 5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d06/4631382/ea8145a50392/nihms731694f5.gif)
Similar articles
-
Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.J Natl Cancer Inst. 1998 Jun 3;90(11):814-23. doi: 10.1093/jnci/90.11.814. J Natl Cancer Inst. 1998. PMID: 9625169 Review.
-
Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.Oral Oncol. 2018 Oct;85:68-81. doi: 10.1016/j.oraloncology.2018.08.015. Epub 2018 Sep 1. Oral Oncol. 2018. PMID: 30220322
-
Dietary fat and chronic diseases: epidemiologic overview.J Am Diet Assoc. 1997 Jul;97(7 Suppl):S9-15. doi: 10.1016/s0002-8223(97)00724-4. J Am Diet Assoc. 1997. PMID: 9216562 Review.
-
Obesity and prostate cancer: weighing the evidence.Eur Urol. 2013 May;63(5):800-9. doi: 10.1016/j.eururo.2012.11.013. Epub 2012 Nov 15. Eur Urol. 2013. PMID: 23219374 Free PMC article. Review.
-
Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions.Am Soc Clin Oncol Educ Book. 2013:52-9. doi: 10.14694/EdBook_AM.2013.33.52. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714455 Review.
Cited by
-
Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial.Clin Interv Aging. 2016 Mar 24;11:367-76. doi: 10.2147/CIA.S94881. eCollection 2016. Clin Interv Aging. 2016. PMID: 27069360 Free PMC article. Clinical Trial.
-
Zinc Supplementation and Body Weight: A Systematic Review and Dose-Response Meta-analysis of Randomized Controlled Trials.Adv Nutr. 2020 Mar 1;11(2):398-411. doi: 10.1093/advances/nmz084. Adv Nutr. 2020. PMID: 31504083 Free PMC article.
-
Sera from women with different metabolic and menopause states differentially regulate cell viability and Akt activation in a breast cancer in-vitro model.PLoS One. 2022 Apr 12;17(4):e0266073. doi: 10.1371/journal.pone.0266073. eCollection 2022. PLoS One. 2022. PMID: 35413055 Free PMC article.
-
Hernia and Cancer: The Points Where the Roads Intersect.Front Surg. 2019 Apr 5;6:19. doi: 10.3389/fsurg.2019.00019. eCollection 2019. Front Surg. 2019. PMID: 31024927 Free PMC article. Review.
-
Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer.Cancers (Basel). 2020 May 28;12(6):1385. doi: 10.3390/cancers12061385. Cancers (Basel). 2020. PMID: 32481537 Free PMC article.
References
-
- Allott EH, Abern MR, Gerber L, Keto CJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Moorman PG, et al. Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database. Prostate Cancer Prostatic Dis. 2013a;16:391–397. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials